By contrast, a significant decrease in 5hmC and TET2 levels was observed in the hippocampus of aged 2×Tg‐AD mice;251 it was suggested that reduced TET2 triggered neuroinflammation in the brains of early‐stage AD patients, resulting in exacerbation of AD progression.251. Here, TET2 is linked to Alzheimer disease.